Cargando…
Dual-Phase PET-CT to Differentiate [(18)F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer
PURPOSE: To investigate whether time-trends of enhanced [(18)F]Fluoromethylcholine ([(18)F]FCH) in lymph nodes (LN) of prostate cancer (PCa) patients can help to discriminate reactive from malignant ones, and whether single time point standardized uptake value (SUV) measurements also suffice. PROCED...
Autores principales: | Oprea-Lager, Daniela E., Vincent, Andrew D., van Moorselaar, Reindert J. A., Gerritsen, Winald R., van den Eertwegh, Alfons J. M., Eriksson, Jonas, Boellaard, Ronald, Hoekstra, Otto S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485217/ https://www.ncbi.nlm.nih.gov/pubmed/23119014 http://dx.doi.org/10.1371/journal.pone.0048430 |
Ejemplares similares
-
A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems
por: Oprea-Lager, Daniela E., et al.
Publicado: (2015) -
Pelvic lymph-node staging with (18)F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
por: Jansen, B. H. E., et al.
Publicado: (2020) -
Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
por: Cysouw, Matthijs C. F., et al.
Publicado: (2020) -
Sensitivity of (18)F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
por: Cysouw, Matthijs C. F., et al.
Publicado: (2019) -
Optimization and validation of (18)F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer
por: Luining, Wietske I., et al.
Publicado: (2023)